A simple approach to predict the stability of phospholipid vesicles to nebulization without performing aerosolization studies

International Journal of Pharmaceutics

Volumn 502, Issue 1-2, 2016, Pages 18-27

  Subramanian, Sneha ^a,b   Khan, Iftikhar ^a,b   Korale, Oshadie ^a,b   Alhnan, Mohamed Albed ^a,b   Ahmed, Waqar ^a,c   Najlah, Mohammad ^d   Taylor, Kevin M G ^e   Elhissi, Abdelbary ^f  

^a UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^b UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^c UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^d ANGLIA RUSKIN UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF LONDON   (United Kingdom)

^f NONE   (Qatar)

Author keywords

Aerosol; Drug delivery; Drug development; Extruder; Nebulizer

Indexed keywords

BECLOMETASONE DIPROPIONATE; CHOLESTEROL; LIPOSOME; POLYCARBONATE; POLYSORBATE 80; SALBUTAMOL SULFATE; AEROSOL; ARTIFICIAL MEMBRANE; BECLOMETASONE; BRONCHODILATING AGENT; PHOSPHOLIPID; POLYCARBOXYLATE CEMENT; POLYSORBATE; SALBUTAMOL;

AEROSOL; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG RETENTION; DRUG SOLUBILITY; DRUG STABILITY; HYDROPHILICITY; HYDROPHOBICITY; MICROSCOPY; NEBULIZATION; PARTICLE SIZE; PHOSPHOLIPID VESICLE; PREDICTION; PRIORITY JOURNAL; REDUCTION; SOYBEAN; ARTIFICIAL MEMBRANE; CHEMISTRY; NEBULIZER; PHARMACEUTICS;

AEROSOLS; ALBUTEROL; BECLOMETHASONE; BRONCHODILATOR AGENTS; CHOLESTEROL; DRUG STABILITY; LIPOSOMES; MEMBRANES, ARTIFICIAL; NEBULIZERS AND VAPORIZERS; PHOSPHOLIPIDS; POLYCARBOXYLATE CEMENT; POLYSORBATES; TECHNOLOGY, PHARMACEUTICAL;

EID: 84958963489     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2016.01.070     Document Type: Article

References (52)

1. R. Batavia, K.M.G. Taylor, D.Q.M. Craig, and M. Thomas The measurement of beclometasone dipropionate entrapment in liposomes: a comparison of a microscope and an HPLC method Int. J. Pharm. 212 2001 109 119
2. E.R. Bendas, and M.I. Tadros Enhanced transdermal delivery of salbutamol sulfate via ethosomes AAPS PharmSciTech 8 2007 E107
3. P.A. Bridges, and K.M.G. Taylor Factors influencing the jet nebulisation of liposomes Int. J. Pharm. 204 2000 69 79
4. J.D. Castile, K.M.G. Taylor, and G. Buckton A high sensitivity differential scanning calorimetry study of the interaction between poloxamers and dimyristoylphosphatidylcholine and dipalmitoylphosphatidylcholine liposomes Int. J. Pharm. 182 1999 101 110
5. J.D. Castile, K.M.G. Taylor, and G. Buckton The influence of incubation temperature and surfactant concentration on the interaction between dimyristoylphosphatidylcholine liposomes and poloxamer surfactants Int. J. Pharm. 221 2001 197 209
6. T.S. Chadha, S. Chattopadhyay, C. Venkataraman, and P. Biswas Study of the charge distribution on liposome particles aerosolized by air-jet atomization J. Aerosol Med. Pulm Drug Deliv. 25 2012 355 364
7. D. Cipolla, I. Gonda, and H.K. Chan Liposomal formulations for inhalation Ther. Deliv. 4 2013 1047 1072
8. D. Cipolla, H. Wu, I. Gonda, and H.K. Chan Aerosol performance and long-term stability of surfactant-associated liposomal ciprofloxacin formulations with modified encapsulation and release properties AAPS PharmSciTech 15 2014 1218 1227
9. J.P. Clancy, L. Dupont, M.W. Konstan, J. Billings, S. Fustik, C.H. Goss, J. Lymp, P. Minic, A.L. Quittner, R.C. Rubenstein, K.R. Young, L. Saiman, J.L. Burns, J.R. Govan, B. Ramsey, R. Gupta, and G. Arikace Study Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection Thorax 68 2013 818 825
10. Y. Darwis, and I.W. Kellaway Nebulisation of rehydrated freeze-dried beclometasone dipropionate liposomes Int. J. Pharm. 215 2001 113 121
11. T.R. Desai, R.E. Hancock, and W.H. Finlay A facile method of delivery of liposomes by nebulization J. Control. Release 84 2002 69 78
12. R. Dhand Nebulizers that use a vibrating mesh or plate with multiple apertures to generate aerosol Respir. Care 47 2002 1406 1416
13. V. Dubey, D. Mishra, A. Asthana, and N.K. Jain Transdermal delivery of a pineal hormone: melatonin via elastic liposomes Biomaterials 27 2006 3491 3496
14. Z. Ehsan, J.D. Wetzel, and J.P. Clancy Nebulized liposomal amikacin for the treatment of Pseudomonas aeruginosa infection in cystic fibrosis patients Expert Opin. Investig. Drugs 23 2014 743 749
15. A.M.A. Elhissi, and K.M.G. Taylor Delivery of liposomes generated from proliposomes using air-jet, ultrasonic, and vibrating-mesh nebulisers J. Drug Deliv. Sci. Technol. 15 2005 261 265
16. A.M. Elhissi, K.K. Karnam, M.R. Danesh-Azari, H.S. Gill, and K.M.G. Taylor Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers J. Pharm. Pharmacol. 58 2006 887 894
17. A.M. Elhissi, M.A. O'Neill, S.A. Roberts, and K.M.G. Taylor A calorimetric study of dimyristoylphosphatidylcholine phase transitions and steroid-liposome interactions for liposomes prepared by thin Film and proliposome methods Int. J. Pharm. 320 2006 124 130
18. A.M. Elhissi, M. Faizi, W.F. Naji, H.S. Gill, and K.M.G. Taylor Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures Int. J. Pharm. 334 2007 62 70
19. A.M.A. Elhissi, M. O'Neill, W. Ahmed, and K.M.G. Taylor High-sensitivity differential scanning calorimetry for measurement of steroid entrapment in nebulised liposomes generated from proliposomes Micro Nano Lett. 6 2011 694 697
20. A.M. Elhissi, J. Giebultowicz, A.A. Stec, P. Wroczynski, W. Ahmed, M.A. Alhnan, D. Phoenix, and K.M.G. Taylor Nebulization of ultradeformable liposomes: the influence of aerosolization mechanism and formulation excipients Int. J. Pharm. 436 2012 519 526
21. M. Fauvel, C. Farrugia, N. Tsapis, C. Gueutin, O. Cabaret, C. Bories, S. Bretagne, and G. Barratt Aerosolized liposomal amphotericin B: prediction of lung deposition, in vitro uptake and cytotoxicity Int. J. Pharm. 436 2012 106 110
22. M.M. Gaspar, A. Radomska, O.L. Gobbo, U. Bakowsky, M.W. Radomski, and C. Ehrhardt Targeted delivery of transferrin-conjugated liposomes to an orthotopic model of lung cancer in nude rats J. Aerosol Med. Pulm Drug. Deliv 25 2012 310 318
23. S.A. Grinshpun, K. Willeke, V. Ulevicius, A. Jouzaitis, S. Terzieva, J. Donnelly, G.N. Stelma, and K.P. Brenner Effect of impaction, bounce and reaerosolization on the collection efficiency of impingers Aerosol Sci. Technol. 26 1997 326 342
24. M.J. Hope, M.B. Bally, L.D. Mayer, A.S. Janoff, and P.R. Cullis Generation of multilamellar phospholipid vesicles Chem. Phys. Lipids 40 1986 89 107
25. H. Kamalaporn, K. Leung, M. Nagel, S. Kittanakom, B. Calvieri, R.A. Reithmeier, and A.L. Coates Aerosolized liposomal Amphotericin B: a potential prophylaxis of invasive pulmonary aspergillosis in immunocompromised patients Pediatr. Pulmonol. 49 2014 574 580
26. I. Khan, S. Yousaf, S. Subramanian, O. Korale, M.A. Alhnan, W. Ahmed, K.M.G. Taylor, and A. Elhissi Proliposome powders prepared using a slurry method for the generation of beclometasone dipropionate liposomes Int. J. Pharm. 496 2015 342 350
27. C. Kirby, and G. Gregoriadis Liposomes E. Mathiowitz, Encyclopaedia of Controlled Drug Delivery 1999 John Wiley NewYork 461 492
28. C. Kirby, J. Clarke, and G. Gregoriadis Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro J. Biochem. 186 1980 591 598
29. E. Kleemann, T. Schmehl, T. Gessler, U. Bakowsky, T. Kissel, and W. Seeger Iloprost-containing liposomes for aerosol application in pulmonary arterial hypertension: formulation aspects and stability Pharm. Res. 24 2007 277 287
30. 99mTc-labeled therapeutic inhaled amikacin loaded liposomes J. Liposome Res. 23 2013 336 342
31. B. Lehofer, F. Bloder, P.P. Jain, L.M. Marsh, G. Leitinger, H. Olshewski, R. Leber, A. Olshewski, and R. Prassl Impact of atomization technique on the stability and transport efficiency of nebulized liposomes harbouring different surface characteristics Eur. J. Pharm. Biopharm. 88 2014 1076 1085
32. J.P. Mitchell, M.W. Nagel, K.J. Wiersema, and C.C. Doyle Aerodynamic particle size analysis from pressurized metered-dose inhalers: comparison of Anderson 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 aerodynamic particle sizer aerosol spectrometer AAPS PharmSciTech 4 2003 E54
33. M. Nasr, I. Taha, and R.M. Hathout Suitability of liposomal carriers for systemic delivery of risedronate using pulmonary route Drug Deliv. 20 2013 311 318
34. M. Nasr, M. Najlah, A. D'Emanuele, and A. Elhissi PAMAM dendrimers as aerosol drug nanocarriers for pulmonary delivery via nebulization Int. J. Pharm. 461 2014 242 250
35. R.W. Niven, and H. Schreier Nebulization of liposomes. I. Effects of lipid composition Pharm. Res. 7 1990 1127 1133
36. R. Niven, M. Speer, and H. Schreier Nebulization of Liposomes. II. The Effects of Size and Modeling of Solute Release Profiles Pharm. Res. 8 1991 217 221
37. R.W. Niven, T.M. Carvajal, and H. Schreier Nebulization of liposomes. III. The effects of operating conditions and local environment Pharm. Res. 9 1992 515 520
38. C. O'Callaghan, and P.W. Barry The science of nebulised drug delivery Thorax 52 Suppl 2 1997 S31 S44
39. F. Olson, C.A. Hunt, F.C. Szoka, W.J. Vail, and D. Papahadjopoulos Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes Biochim. Biophys. Acta 557 1979 9 23
40. M. Saari, M.T. Vidgren, M.O. Koskinen, V.M. Turjanmaa, and M.M. Nieminen Pulmonary distribution and clearance of two beclomethasone liposome formulations in healthy volunteers Int. J. Pharm. 181 1999 1 9
41. D.J. Serisier, D. Bilton, A. De Soyza, P.J. Thompson, J. Kolbe, H.W. Greville, D. Cipolla, P. Bruinenberg, and I. Gonda ORBIT-2 investigators,. Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial Thorax 68 2013 812 817
42. U.D. Shivhare, P.B. Surse, and V.S. Thombare Formulations and in-vitro evaluation of salbutamol sulphate liposomes Am. J. Pharm. Res. 2 2012 970 981
43. J.C.M. Stewart Colorimetric determination of phospholipids with ammonium ferrothiocyanate Anal. Biochem. 104 1980 10 14
44. T. Subongkot, B. Pamornpathomkul, T. Rojanarata, P. Opanasopit, and T. Ngawhirunpat Investigation of the mechanism of enhanced skin penetration by ultradeformable liposomes Int. J. Nanomed. 9 2014 3539 3550
45. K.M.G. Taylor, G. Taylor, I.W. Kellaway, and J. Stevens The influence of liposomal encapsulation on sodium cromoglycate pharmacokinetics in man Pharm. Res. 6 1989 633 636
46. K.M.G. Taylor, G. Taylor, I.W. Kellaway, and J. Stevens Drug entrapment and release from multilamellar and reverse-phase evaporation liposomes Int. J. Pharm. 58 1990 49 55
47. K.M.G. Taylor, G. Taylor, I.W. Kellaway, and J. Stevens The stability of liposomes to nebulisation Int. J. Pharm. 58 1990 57 61
48. L.P. Tseng, H.J. Liang, T.W. Chung, Y.Y. Huang, and D.Z. Liu Liposomes incorporated with cholesterol for drug release triggered by Magnetic field J. Med. Biol. Eng. 27 2007 29 34
49. D.D. Verma, S. Verma, G. Blume, and A. Fahr Particle size of liposomes influences dermal delivery of substances into skin Int. J. Pharm. 258 2003 141 151
50. V. Waters, and F. Ratjen Inhaled liposomal amikacin Expert Rev. Respir. Med. 8 2014 401 409
51. M. Xu, K. Willeke, P. Biswas, and S.E. Partsinis Impaction and rebound of particles at acute incident angles Aerosol Sci. Technol. 18 1993 143 155
52. M. Young, M. Dinda, and M. Singer Effect of Tween 80 on lipid vesicle permeability Biochim. Biophys. Acta 735 1983 429 432